Work

High Relapse Rate Following Alemtuzamab Use in Allogeneic Transplants for Myeloid Hematologic Malignancies.

Year: 2004

Type: article

Source: Blood

DOI: 10.1182/blood.v104.11.1826.1826

Authors: Thomas C. Shea, Jonathan Serody, Don Gabriel, Terrance Comeau, Donald Harvey, Robert Irons, David Morris, Andrew Sharf, Carol Krasnov, Cherie Dunphy, Nicholas Banderenko, Mark Brecher

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560655172

FWCI:

Cites:

Cited by:

Related to: 10